Riverarch Equity Partners (“Riverarch”) and other investors, including Audax Strategic Capital, The Hillman Company, Lacy Diversified, and PPM America, together with their portfolio company TCP Analytical are pleased to announce the acquisition of AAPPTec, LLC (“AAPPTec” or the “Company”), a leading provider of peptide synthesis products to life sciences customers.

Based in Louisville, KY, AAPPTec is a leading provider of materials utilized in the synthesis, purification, and isolation of peptides. The Company provides innovative automated and semi-automated synthesizers worldwide for research and industrial scale production. AAPPTec also offers top quality resins, reagents and amino acid derivatives, including pseudoproline dipeptides, isoacyl dipeptides, PEGylation reagents, glyco-amino acids and products for stapled peptides. AAPPTec was founded in 2005 by renowned peptide chemist, Dr. Hossain Saneii.

Al Jurgela, CEO of TCP Analytical, commented, “We are excited at the opportunity to partner with AAPPTec. The Company has an exceptional performance track record supported by an industry leading portfolio of innovative products and unparalleled scientific expertise and customer support. We look forward to building upon the brand’s stellar legacy and to expand further into a highly attractive segment within life sciences.”

Dr. Saneii, President of AAPPTec stated, “We are thrilled to partner with TCP to accelerate our new product introductions, customer acquisition, and overall growth trajectory.  Our partnership presents compelling opportunities to leverage TCP’s existing complementary peptides business and extensive customer base.”

TCP Analytical is an integrated manufacturer and distributor of specialty chemicals and consumable products to the life sciences and general industrial markets. TCP Analytical’s comprehensive product portfolio supports customers’ critical testing and production processes through innovative custom solutions, reliable performance, and exceptional customer service.

Riverarch Equity Partners is a middle market private equity firm that seeks well positioned companies where it can invest in support of leveraged and management buyouts, corporate divestitures, and growth financings. The firm is based in Pittsburgh, Pennsylvania.